333 Assessment of Spent Hemp Biomass as a Potential Feedstuff in Ruminant Diets

The 2018 Farm Bill removed hemp (Cannabis sativa) from the Controlled Substances Act, classifying it as an agricultural product. The process of cannabidiol extraction from hemp yields large quantities of spent hemp biomass (SHB) that may potentially be included in animal diets. However, the use of SHB in animal diets has not been approved by FDA yet since its effect on animal health, production and product quality is still unknown. Thus, a feeding study was carried out to investigate the effects of varying levels of SHB and a four-week withdrawal period on feed intake and liveweight gains of weaned lambs. A total of 35 weaned, male Polypay lambs kept in single pens were randomly assigned to five feeding treatments (n=7) and fed diets containing either no SHB (CON) or SHB at 10% (LH1) or 20% (HH1) for 4 weeks with 4 weeks withdrawal from SHB, or SHB at 10 (LH2) or 20% (HH2) for 8 weeks. The nutritive analysis of the SHB indicated a high-quality feed, with 20% (DM) crude protein and 27% NDF. Dry matter (DM) intake of lambs was negatively affected by 20% SHB during the first period. In the second period, DM intake was larger in lambs fed 10% SHB vs. CON, with the largest feed intake observed in HH1 lambs. In contrast, none of the performance data, including liveweight gains, were different across the groups and periods. Feeding 20% SHB decreased plasma cholesterol, NEFA, BHBA, Ca, and Cl and increased urea and Mg, while 10% SHB increased glucose, cholesterol, and NEFA. Our findings indicated that 10% SHB can be included in ruminant diets without causing any detrimental effect on performance with a possible positive effect on feed intake. The long-term feeding of 20% SHB strongly affects the metabolism.

A Study on Performance of Regulated Markets in Tamil Nadu

The aim of the paper is to study the performance of regulated markets in TamilNadu . Regulated markets are essential for regulating and monitoring the financial and economic system thereby reducing market charges and providing facilities to producers and sellers in the market. At present in Tamil Nadu 284 regulated markets are functioning under 23 market committees to ensure fair prices to farmers produce. The primary data were collected by structured questionnaire to study the constraints faced by the farmers in regulated market and also the brain storming session were conducted between market committee, farmers, traders, FPO’s(Farmer Producer Organisation), etc.. to improve the efficiency of regulated market. The secondary data were collected from District market committees. The tools used in this study are Percentage analysis and Garett ranking method. The results shows that nearly 80 to 90 percent of Market fee collected outside, for the sale and purchase of notified agricultural produce would be affected due to the farm bill 2020 and this problems can be fairly rectified by some alternative measures or models in which market shops construction, Primary processing centres, etc.. will improve the performance of the regulated market. The major constraints faced by the farmers was high transportation cost.

Farmers’ Agitation in India Due to Audacious Farm Bill of 2020

Farmers are doing primary and significant duty for the society by engaging in agriculture. They are tirelessly ploughing the field, planting the seed, watering the land and yielding crops. Production of cereals, pulses, fruits and vegetable are necessary to feed people of billion plus nation and ensuring food security. It is necessity of the government to provide necessary support with legislation of law, enactment of the same, crop insurance and provision of subsidy for agricultural inputs. There should be advancement in irrigation facility, application of biotechnology, credit facility, land reform and availability of market. But new framed agricultural reform act enraged the farmers and injected fear in their mind. Farmers feel apprehensive regarding the restructuring of the Indian agriculture. There is a shadow of uncertainty about annulment of minimum support price facility. It is presumed that new farm bill would take away Mandi facility which so far gave assurance to selling of crop. Although middle men were involved in the process, farmers were sanguine about selling of agricultural output with intermediation of them. Farmers so far enjoyed crop insurance and minimum support price for agricultural output. But newly passed bill in parliament spread tension among farmers about future uncertainties. Fear and ambiguity lingered with respect to corporate support and assurance. Loss of land and livelihood to corporate also gripped the minds. Question revolved about farmers wherewithal and whereabouts if corporates fail to buy crop or agricultural output. Like majority of Indian citizen, farmers are devoid of social security measure. Corporate indifference might cause grave loss for poor farmers in the absence of safety net. But sticking to this defunct system, would result in more harm than good for Indian farmers.

Did the 2018 Farm Bill’s Hemp Provisions Decriminalize Marijuana?

In 2014, Congress removed industrial hemp with a concentration of ≥0.3% tetrahydrocannabinol (THC) dry weight from the definition of marijuana in the federal Controlled Substances Act (CSA). Hemp production was authorized in a limited pilot program until 2018, when Congress passed the Agricultural Improvement Act (Farm Bill) that expanded the program to anyone licensed to produce hemp by the U.S. Department of Agriculture (USDA) or by a USDA-approved State or Indian tribe. Hemp’s greatest value is in two of its 80-plus molecules: cannabidiol (CBD) and THC. These molecules, present in all forms of Cannabis sativa L. (cannabis), including hemp, have medicinal and recreational uses. By removing hemp from the CSA, the Farm Bill altered the legal status of hemp’s extracts, including CBD and THC. In 2018, Epidiolex®, the world’s first and only CBD-based medicine, was approved in the U.S. The drug was placed in Schedule V of the CSA to comply with an international drug treaty requiring control of cannabis and all its extracts. In April 2020, Epidiolex was removed from the CSA schedules. This occurred, according to the Drug Enforcement Administration (DEA), because with a THC content below 0.3%, Epidiolex no longer met the Farm Bill’s criteria as a controlled substance. This review discusses the Farm Bill’s hemp provisions and how they have affected the legal status of hemp derivatives CBD and THC. The review also discusses a loophole in the Farm Bill that decriminalizes the production of marijuana by negligent hemp farmers. In passing, we discuss how lobbying by the hemp/CBD industry influenced passage of the Farm Bill.

Consumption of Foods Derived from Subsidized Crops Remains Associated with Cardiometabolic Risk: An Update on the Evidence Using the National Health and Nutrition Examination Survey 2009–2014

In this study, we examined the associations between the consumption of foods derived from crops subsidized under the 2008 United States (US) Farm Bill and cardiometabolic risk factors and whether the magnitude of these associations has changed since the 2002 US Farm Bill. Four federal databases were used to estimate daily consumption of the top seven subsidized commodities (corn, soybeans, wheat, rice, sorghum, dairy, and livestock) and to calculate a subsidy score (0–1 scale) for Americans’ daily dietary intake during 2009–2014, with a higher score indicative of a higher proportion of the diet derived from subsidized commodities. The cardiometabolic risk factors included obesity, abdominal adiposity, hypertension, dyslipidemia, and dysglycemia. Linear and logistic regression models were adjusted for age, sex, race/ethnicity, the poverty–income ratio, the smoking status, educational attainment, physical activity, and daily calorie intake. During 2009–2014, adults with the highest subsidy score had higher probabilities of obesity, abdominal adiposity, and dysglycemia compared to the lowest subsidy score. After the 2002 Farm Bill (measured using data from 2001–2006), the subsidy score decreased from 56% to 50% and associations between consuming a highly-subsidized diet and dysglycemia did not change (p = 0.54), whereas associations with obesity (p = 0.004) and abdominal adiposity (p = 0.002) significantly attenuated by more than half. The proportion of calories derived from subsidized food commodities continues to be associated with adverse cardiometabolic risk factors, though the relationship with obesity and abdominal adiposity has weakened in recent years.

Wild Wild West: Emerging Viruses and Viroids of Hemp

Hemp (Cannabis sativa) or industrial hemp is a rapidly growing industry in the United States. However, the crop has been poorly studied in the US since its production declined in the late 1950s, and information on the biological and agricultural factors affecting hemp is limited. With the passage of the 2014 Farm Bill, hemp is no longer considered an illegal plant and is now a legal agricultural crop in the US. Within the bill, Section 7606 (Legitimacy of Industrial Hemp Research) provided a formal definition of the crop as "the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-9-tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis". In addition, the 2018 Farm Bill addressed many issues that had previously impeded development of the crop. Currently, 46 US states have enacted laws removing barriers to its production. In 2019, hemp production was 206, 965 hectares with 16,877 grower licenses across 34 states, according to "US Hemp Report" (www.votehemp.com). This is a greater than 455% increase over 2018 licensed acreage. Colorado, the leading state in hemp production increased production from 4,873 licensed hectares (346 growers) in 2017 to 12,525 licensed hectares (835 growers) in 2018. The US retail sales of hemp products was reported at $1.2 billion in 2018. The most profitable market for North American hemp is oilseed production and cannabidiol (CBD), a nonintoxicant cannabinoid with promising therapeutic use as a pharmaceutical product. Current CBD sales are estimated at $190 million and are projected to reach $2.5 billion by 2022. As we enter this new era of hemp production, plant diseases associated with the crop in the US and associated disease management needs are essentially undescribed. The emergence of phytopathogens and their spread is a rising concern as hemp production increases. Therefore, there is an urgent need to identify emerging and established hemp viruses and viroids, elucidate their diversity and distribution, develop early pathogen detection tools, and provide hemp growers, industry and other stakeholders information and resources to make timely management decision and minimize crop loss.